Investigating cardiovascular diseases related to endocrine therapy in hormone receptor-positive early breast cancer: insights from a nationwide real-world study

Investigating cardiovascular diseases related to endocrine therapy in hormone receptor-positive early breast cancer: insights from a nationwide real-world study

Abstract Background Breast cancer (BC) patients face abnormal lipid metabolism and increased cardiovascular disease (CVD) risk due to endocrine therapies (ETs). This study evaluates CVD incidence and lipid abnormalities in Chinese patients with early-stage hormone receptor-positive (HR+) BC to infor...

Full description

Saved in:
Bibliographic Details
Main Authors: Cheng Zeng, Hong Li, Wenna Wang, Lixi Li, Binliang Liu, Bo Lan, Qing Li, Wenjing Yang, Jiani Wang, Fei Ma
Format: Article
Language:English
Published: BMC 2025-04-01
Series:Cardio-Oncology
Subjects:
Breast cancer
Lipid
Endocrine therapy
Cardiovascular events
Online Access:https://doi.org/10.1186/s40959-025-00333-6
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s40959-025-00333-6

Similar Items